Preliminary classification of the identified antigens based on their differential expression both in the cancer antigen array and shotgun proteomics experiment showed that of these 5 antigens, only COL6A1, FGFR2 and CALM1 demonstrated promise as biomarkers of PCa by both approaches. This evidence concerns the gene FGFR2 and cancer.